The DOI matches its Crossref record; 27 of the 28 references it cites were found in a registry or an index.
Impact of Intensive Glycemic Control on the Incidence of Atrial Fibrillation and Associated Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus (from the Action to Control Cardiovascular Risk in Diabetes Study)
Open accessAbstract
Atrial fibrillation (AF) is prevalent in patients with type 2 diabetes mellitus (DM) and is associated with markers of poor glycemic control; however, the impact of glycemic control on incident AF and outcomes is unknown. The aims of this study were to prospectively evaluate if intensive glycemic control in patients with DM affects incident AF and to evaluate morbidity and mortality in patients with DM and incident AF. A total of 10,082 patients with DM from the Action to Control Cardiovascular Risk in Diabetes (ACCORD) cohort were studied in a randomized, double-blind fashion. Participants were randomized to an intensive therapeutic strategy targeting a glycated hemoglobin level of <6.0% or a standard strategy targeting a glycated hemoglobin level of 7.0% to 7.9%. Incident AF occurred in 159 patients (1.58%) over the follow-up period, at a rate of 5.9 per 1,000 patient-years in the intensive-therapy group and a rate of 6.37 per 1,000 patient-years in the standard-therapy group (p = 0.52). In a multivariate model, predictors of incident AF were age, weight, diastolic blood pressure, heart rate, and heart failure history. Patients with DM and new-onset AF had a hazard ratio of 2.65 for all-cause mortality (95% confidence interval 1.8 to 3.86, p <0.0001), a hazard ratio of 2.1 for myocardial infarction (95% confidence interval 1.33 to 3.31, p = 0.0015), and a hazard ratio of 3.80 for the development of heart failure (95% confidence interval 2.48 to 5.84, p <0.0001). In conclusion, intensive glycemic control did not affect the rate of new-onset AF. Patients with DM and incident AF had an increased risk for morbidity and mortality compared with those without AF.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Unfortunately, intensive glycaemic control does not affect the rate of new-onset AF”
From 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS (2016) · cites this paper as [284]
In the citing paper
“Diabetes is a risk factor for stroke and other complications in AF.”
From 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS (2016) · cites this paper as [284]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Effects of Intensive Glucose Lowering in Type 2 Diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802743 · Cited by 7,888
Benjamin, E. J. (1994) · JAMA · doi:10.1001/jama.1994.03510350050036 · Cited by 2,613
Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study
Heeringa, J., van der Kuip, D. A. M., Hofman, A., Kors, J. A., van Herpen, G., Stricker, B. H. C., Stijnen, T., Lip, G. Y. H., & Witteman, J. C. M. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehi825 · Cited by 1,939
Obesity and the risk of new-onset atrial fibrillation
Wang, T. J. (2004) · JAMA · doi:10.1001/jama.292.20.2471 · Cited by 1,427
Inflammation in Atrial Fibrillation
Guo, Y., Lip, G. Y. H., & Apostolakis, S. Z. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.04.063 · Cited by 868
Lazar, H. L., Chipkin, S. R., Fitzgerald, C. A., Bao, Y., Cabral, H., & Apstein, C. S. (2004) · Circulation · doi:10.1161/01.cir.0000121747.71054.79 · Cited by 713
Prineas, R. J., Crow, R. S., & BLACKBURN, H. W. (1982) · Cited by 701
Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial: Design and Methods
Buse, J. B. (2007) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2007.03.003 · Cited by 661
Huxley, R., Filion, K. B., Konety, S., & Alonso, Á. (2011) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2011.03.004 · Cited by 578
Recent advances in the molecular pathophysiology of atrial fibrillation
Wakili, R., Voigt, N., Kääb, S., Dobrev, D., & Nattel, S. (2011) · Journal of Clinical Investigation · doi:10.1172/jci46315 · Cited by 543
Flagged first, then by citations
1 of the 28 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 101–173 of 173
Abbaszadeh, S., Shafiee, A., Bina, P., Jalali, A., Sadeghian, S., & Karimi, A. (2017) · Critical Pathways in Cardiology A Journal of Evidence-Based Medicine · doi:10.1097/hpc.0000000000000103 · Cited by 10
Life’s Simple 7 Approach to Atrial Fibrillation Prevention
Sperling, L. S. (2018) · Journal of Atrial Fibrillation · doi:10.4022/jafib.2051 · Cited by 11
Iqbal, A., Tekin, Z., Kattan, M. W., Ji, X., Milinovich, A., Pantalone, K. M., Zimmerman, R. S., Chung, M. K., & Kashyap, S. R. (2022) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2022.108315 · Cited by 9
Kim, M. H., Ha, K. H., Lee, J. H., Park, S., Oh, K. S., Bae, D., Lee, J., Kim, S.-M., Choi, W., Hwang, K., et al. (2024) · Korean Circulation Journal · doi:10.4070/kcj.2023.0234 · Cited by 8
Risk factor modification for the primary and secondary prevention of atrial fibrillation. Part 1
Mujović, N. M., Marinković, M. M., Mihajlovic, M., Mujović, N., & Potpara, T. (2020) · Kardiologia Polska · doi:10.33963/kp.15221 · Cited by 9
Pomero, F., Dentali, F., Mumoli, N., Salomone, P., Tangianu, F., Desideri, G., & Mastroiacovo, D. (2019) · Acta Diabetologica · doi:10.1007/s00592-019-01426-2 · Cited by 7
Modifiable Risk Factors and Atrial Fibrillation: the Quest for a Personalized Approach
Matei, L.-L., Silişte, C., & Vinereanu, D. (2021) · MAEDICA – a Journal of Clinical Medicine · doi:10.26574/maedica.2020.16.1.88 · Cited by 8
Huang, D., Huang, Y., Zhang, Q.-Y., Cui, Y., Mu, T., & Huang, Y. C. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.777233 · Cited by 8
Risk factor modification for the primary and secondary prevention of atrial fibrillation. Part 2
Nebojša, M., Marinković, M., Mihajlovic, M., Mujović, N., & Potpara, T. (2020) · Kardiologia Polska · doi:10.33963/kp.15240 · Cited by 7
Kuang, R.-R., Liu, F., Li, Y., Lin, W., Liang, H., & Chen, A. (2017) · European journal of medical research · doi:10.1186/s40001-017-0257-x · Cited by 7
Daios, S., Savopoulos, C. G., Kanellos, I., Goudis, C. A., Nakou, I., Petaloti, S., Hadjidimitriou, N., Pilalas, D., Ziakas, A., & Kaiafa, G. D. (2021) · Medicina · doi:10.3390/medicina57010041 · Cited by 8
Özcan, E. E. (2018) · The Anatolian Journal of Cardiology · doi:10.14744/anatoljcardiol.2018.87260 · Cited by 8
Nishikawa, T., Tanaka, Y., Tada, H., Tsuda, T., Kato, T., Usui, S., Sakata, K., Hayashi, K., Kawashiri, M., Hashiba, A., et al. (2021) · Nutrients · doi:10.3390/nu13093201 · Cited by 6
Incidence of atrial fibrillation in elderly patients with type 2 diabetes mellitus
Matsumoto, C., Ogawa, H., Saito, Y., Okada, S., Soejima, H., Sakuma, M., Masuda, I., Nakayama, M., Doi, N., Jinnouchi, H., et al. (2022) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2021-002745 · Cited by 6
The combination of atrial fibrillation and obstructive sleep apnea — is there a connection?
Arutyunyan, G. G., Викторович, А. М., Davtyan, K. V., & Drapkina, O. M. (2018) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2018-12-119-124 · Cited by 6
Hosseinsabet, A., Badalabadi, R. M., & Moinfar, A. (2016) · Journal of Ultrasound in Medicine · doi:10.7863/ultra.15.12065 · Cited by 6
Atrial fibrillation: an underappreciated complication of diabetes
Cai, L., Wan, H., Sun, Y., Middeldorp, M. E., Zhang, Y., Qi, L., Sanders, P., Wang, H., Shi, Y., Zhou, J., et al. (2026) · European Heart Journal · doi:10.1093/eurheartj/ehag044 · Cited by 5
Addressing Extracardiac Risk Factors to Improve Atrial Fibrillation Treatment Outcomes
Andrade, J. G., & Macle, L. (2019) · Journal of Innovations in Cardiac Rhythm Management · doi:10.19102/icrm.2019.101103 · Cited by 5
Prevalence and predictors of atrial fibrillation in Japanese patients with type 2 diabetes
Otake, S., Sato, A., & Babazono, T. (2021) · Diabetology International · doi:10.1007/s13340-021-00509-2 · Cited by 5
Aldafas, R., Crabtree, T. S. J., Vinogradova, Y., Gordon, J. P., & IDRIS, I. R. (2023) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2023.2166489 · Cited by 5
Hermans, M. P., Bouénizabila, E., Amoussou-Guénou, D., Ahn, S. A., & Rousseau, M. F. (2015) · Cardiovascular Diabetology · doi:10.1186/s12933-015-0226-z · Cited by 4
Antithrombotic treatment gap among patients with atrial fibrillation and type 2 diabetes
Guimarães, P. O., Peterson, E. D., Stevens, S. R., Lokhnygina, Y. V., Green, J. B., McGuire, D. K., Holman, R. R., & Lópes, R. D. (2019) · International Journal of Cardiology · doi:10.1016/j.ijcard.2019.04.085 · Cited by 4
for the RACE 3 investigators, With, R. R. D., Rienstra, M., Crijns, H. J. G. M., & Gelder, I. C. V. (2019) · Clinical Research in Cardiology · doi:10.1007/s00392-019-01581-0 · Cited by 4
Канорский, С. Г., & Kovalenko, Y. S. (2023) · South Russian Journal of Therapeutic Practice · doi:10.21886/2712-8156-2023-4-1-19-27 · Cited by 3
Concomitant Diabetes and Atrial Fibrillation: Epicardial Fat and Macrophage‐Related Mechanisms
Al‐rubaye, S., Rodríguez‐Mañero, M., González‐Juanatey, J. R., & Eirás, S. (2025) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.70065 · Cited by 3
(2019) · Clinical pharmacology and therapy · doi:10.32756/0869-5490-2019-3-5-13 · Cited by 3
Cardiac arrhythmias in patients with type 2 diabetes mellitus
Омариевна, У. Ф., Izmaylova, M. Y., & Николаевна, Н. М. (2024) · FOCUS Endocrinology · doi:10.62751/2713-0177-2024-5-2-12 · Cited by 3
Liu, Y., Yang, C., Lam, S. H. M., Huang, B., Romiti, G. F., Alam, U., Chao, T., Olshansky, B., Hong, K., Huisman, M. V., et al. (2024) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15950 · Cited by 4
Koniari, I. C., Bozika, M., Nastouli, K.-M., Tzegka, D., Apostolos, A., Velissaris, D., Leventopoulos, G., Perperis, A., Kounis, N. G., Tsigkas, G., et al. (2025) · Biomedicines · doi:10.3390/biomedicines13020405 · Cited by 4
Grigore, M., Grigore, A.-M., Ruxandra-Elena, M.-G., Verde, I., Uscoiu, G., Nicolae, C., Balahura, A.-M., & Ilieşiu, A. (2025) · Life · doi:10.3390/life16010016 · Cited by 2
Complex interrelationship and therapeutic advances in diabetic patients with atrial fibrillation
Karanikola, A.-E., Tsiachris, D., Argyriou, N., Botis, M., Pamporis, K., Xydis, P., Fragoulis, C., Kordalis, A., & Tsioufis, K. P. (2025) · World Journal of Cardiology · doi:10.4330/wjc.v17.i12.114575 · Cited by 2
Glucose metabolic dysregulation of diabetes and Its role in atrial fibrillation pathogenesis
Chen, Y., Xu, M., Wei, K., & Ma, N. (2026) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2025.1711069 · Cited by 2
Gumprecht, J. J., Lip, G. Y. H., Sokal, A., Średniawa, B., Stokwiszewski, J., Zdrojewski, T. R., Rutkowski, M., Grodzicki, T. K., Kaźmierczak, J., Opolski, G., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-43939-5 · Cited by 3
Kikuko, I. H., Julario, R., Puspitasari, A. N., Intan, R. E., Azmi, Y., Fatimah, F. N., Savitri, C. G., Firmanda, D. R., Suhandoko, L. P., & Dini, A. S. F. (2023) · Journal of Arrhythmia · doi:10.1002/joa3.12938 · Cited by 2
Lee, S.-R., Lee, Y.-S., Lim, W., Kim, T.-H., Cha, M., Lee, J., Baek, Y., Lim, H., Joung, B., Kim, J., et al. (2018) · Korean Journal of Medicine · doi:10.3904/kjm.2018.93.4.324 · Cited by 2
Hessellund, A. K., Haugan, K., Xing, L. Y., Kongebro, E. K., Vad, O. B., Graff, C., Spona, D. C., Baadsgaard, J. A., Andersen, A., Hædersdal, S., et al. (2026) · International Journal of Cardiology · doi:10.1016/j.ijcard.2026.134727 · Cited by 1
Prevención primaria en fibrilación auricular
Montero-Rincón, G. A. (2016) · Revista Colombiana de Cardiología · doi:10.1016/j.rccar.2016.10.028 · Cited by 1
Is atrial fibrillation another manifestation of organ damage in diabetes?
Miyazawa, K., & Lip, G. Y. H. (2017) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(17)30282-6 · Cited by 1
Modern approaches to the treatment of atrial fibrillation in patients with diabetes mellitus.
Serik, S. A., & Strona, V. I. (2022) · Shidnoevropejskij zurnal vnutrisnoi ta simejnoi medicini · doi:10.15407/internalmed2022.01.069 · Cited by 1
Cardiometabolic diseases—Recent advance in antithrombotic and thrombolytic therapies
Nikolovski, S. S., Jeske, W. P., & Fareed, J. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-95469-3.00006-1 · Cited by 1
Singhal, M., McAdam-Marx, C., Lafleur, J., Witt, D., Nelson, R., & Biskupiak, J. E. (2016) · Value in Health · doi:10.1016/j.jval.2016.03.254 · Cited by 1
Koziolova, N. A., Polyanskaya, Е. А., Суровцева, М. В., & Karavaev, P. G. (2018) · Kardiologiia · doi:10.18087/cardio.2018.4.10114 · Cited by 1
Role for risk factor treatment in the management of atrial fibrillation
Frenkel, D., & Aronow, W. S. (2020) · Hospital Practice · doi:10.1080/21548331.2020.1784663 · Cited by 1
Барбараш, О. Л., & Кашталап, В. В. (2020) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2020-4131 · Cited by 1
Atrial fibrillation in diabetic patients.
Serik, S. A., & Strona, V. I. (2021) · Shidnoevropejskij zurnal vnutrisnoi ta simejnoi medicini · doi:10.15407/internalmed2021.02.103 · Cited by 1
Gumprecht, J. J., & Kalarus, Z. F. (2022) · Wiadomości Lekarskie · doi:10.36740/wlek202201123 · Cited by 1
Concomitant Diabetes and Atrial Fibrillation
Bloomgarden, Z. T., Kosiborod, M., & Handelsman, Y. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.07.773 · Cited by 1
Diagnostic Testing in the Emergency Department of Atrial Fibrillation
Thomas, A., & Rafique, Z. (2016) · Contemporary cardiology · doi:10.1007/978-3-319-31386-3_8
Breitenstein, A., & Steffel, J. (2017) · Praxis · doi:10.1024/1661-8157/a002725
Кanorskiy, S. G. (2018) · Kardiologiia · doi:10.18087/cardio.2469
ATRIAL FIBRILLATION IN PATIENT WITH DIABETES MELLITUS 2 TYPE: CO-EXISTANCE AND THERAPEUTIC APROCHES
Makharynska, O. S., Fagbemi Oluwatoyin, O., Doroshenko, O. M., & Пожар, В. Й. (2018) · The Journal of V N Karazin Kharkiv National University series Medicine · doi:10.26565/2313-6693-2018-35-16
Interventionen am diabetischen Herzen
Zweiker, R., Zirlik, A., & Scherr, D. (2019) · Der Diabetologe · doi:10.1007/s11428-019-00554-1
Tangianu, G. E. F., & Nardi, R. (2019) · Italian Journal of Medicine · doi:10.4081/itjm.q.2019.8
Antiarrhythmic Properties of Non-Antiarrhythmic Drugs in Atrial Fibrillation: Upstream Therapy
Scridon, A., & Martínez‐Rubio, A. (2020) · Springer eBooks · doi:10.1007/978-3-030-34893-9_7
Drobotya, N. V., Guseynova, E. S., & Пироженко, А. А. (2020) · Rational Pharmacotherapy in Cardiology · doi:10.20996/1819-6446-2020-04-06
Prevention of Atrial Fibrillation
Kornej, J., & Benjamin, E. J. (2020) · Contemporary cardiology · doi:10.1007/978-3-030-56279-3_23
Role of Insulin Resistance in the Development of Atrial Fibrillation
YİĞİT, E., & Erciyes, D. (2022) · Namık Kemal Tıp Dergisi · doi:10.4274/nkmj.galenos.2022.31932 · Cited by 1
Agewall, S., Roldán, V., & Marín, F. R. (2023) · Oxford University Press eBooks · doi:10.1093/med/9780192869227.003.0027
Non-antiarrhythmic Drugs with Antiarrhythmic Properties
Scridon, A., Ivănescu, A. C., & Halațiu, V.-B. (2024) · Springer eBooks · doi:10.1007/978-3-031-74046-6_8
AAD in Patients with Comorbidities
Sartiani, L., & Cerbai, E. (2024) · Springer eBooks · doi:10.1007/978-3-031-74046-6_14
Cui, D., Xu, H., Fu, X., Ma, S., & Bee, Y. M. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1472846
Cardiac arrhythmias and diabetes mellitus: What a clinician needs to know
Nadybina, M. N., Омариевна, У. Ф., & Izmaylova, T. Y. (2025) · FOCUS Endocrinology · doi:10.62751/2713-0177-2025-6-2-05
The Predictive Value of NT-proBNP for New-Onset Atrial Fibrillation in Patients with ArrhythmiaPreprint
Duong, H. K. L., Doan, S., Lam, V. N., Tran, T. V., Kieu, N. T., & Nguyen, T. T. (2025) · Research Square · doi:10.21203/rs.3.rs-7803439/v1
Seyed Ahmadi, S., Svensson, A.-M., Pivodic, A., Rosengren, A., & Lind, M. (2020) · Figshare · doi:10.6084/m9.figshare.11960148
Hsu, J.-C., Yang, Y.-Y., Chuang, S.-L., Yu, C., & Lin, L.-Y. (2021) · Figshare · doi:10.6084/m9.figshare.15047632
Gumprecht, J., Lip, G. Y. H., Sokal, A., Średniawa, B., Stokwiszewski, J., Zdrojewski, T., Rutkowski, M., Grodzicki, T., Kaźmierczak, J., Opolski, G., et al. (2023) · Research Square · doi:10.21203/rs.3.rs-2517000/v1
Research Progress on the Relationship between Type 2 Diabetes Mellitus and Atrial Fibrillation
Liu, B.-Y. (2025) · Advances in Clinical Medicine · doi:10.12677/acm.2025.15102981
Tran, V. T., Duong, L. H. K., Doan, S., Lam, N. V., Kieu, D. N., & Nguyen, T. T. (2026) · Biomedicines · doi:10.3390/biomedicines14061252
Ye, X., Wu, Q., Hou, L., Hou, X., Yang, Y., Yang, C., Huang, M., & Wang, S. (2026) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.70202
Zakeri, R., Camilli, M., D’Elia, E., Hulot, J., Iacoviello, M., Sisti, N., Țica, O., Tokmakova, M. P., den Eynde, J. V., Weerts, J., et al. (2026) · European Journal of Heart Failure · doi:10.1093/ejhf/xuag268
Choi, E., Middeldorp, M. E., Ahn, H., Ariyaratnam, J., Elliott, A. D., Hung, C., Yu, H. T., Sharma, G., Wang, N., Yamaguchi, T., et al. (2026) · Journal of Arrhythmia · doi:10.1002/joa3.70490
Metadata
- Authors
- Fatemi, O., Yuriditsky, E., Tsioufis, C., Tsachris, D., Morgan, T., Basile, J., Bigger, T., Cushman, W., Goff, D., Soliman, E. Z., Thomas, A., & Papademetriou, V.
- Affiliations
- MedStar Washington Hospital Center (US)
- National and Kapodistrian University of Athens (GR)
- Atrium Health Wake Forest Baptist (US)
- Medical University of South Carolina (US)
- Columbia University Irving Medical Center (US)
- University of Tennessee Health Science Center (US)
- Colorado School of Public Health (US)
- Henry Ford Health (US)
- Georgetown University (US)
- Corresponding author
- Yuriditsky, Eugene
- ORCID
- Venue
- The American Journal of Cardiology
- Publisher
- Elsevier BV
- Published
- 2014-10
- Volume
- 114
- Issue
- 8
- Pages
- 1217-1222
- ISSN
- 0002-9149 (ISSN-L)
- PMC
- PMC4291278
- OpenAlex
- W2020081546
- Cited by
- 173
- References
- 28
- Citations by year
- 2026: 8 · 2025: 10 · 2024: 12 · 2023: 16 · 2022: 18 · 2021: 21 · 2020: 20 · 2019: 15 · 2018: 17 · 2017: 14 · 2016: 13 · 2015: 9
- FWCI
- 8.22
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- The American Journal of Cardiology (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (n01hc95184-24-0-1, n01hc95182-23-0-1)
- National Heart, Lung, and Blood Institute (N01 HC095184, N01 HC095182, Y01 HC001010, Y01 HC009035)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- atrial fibrillation, type 2 diabetes, tight glycemic control, HbA1c, cardiovascular outcomes, all-cause mortality, myocardial infarction, heart failure, atrial fibrillation risk factors, ACCORD trial
- MeSH terms
- Adult, Aged, Atrial Fibrillation, Blood Glucose, Canada, Diabetes Mellitus, Type 2, Dose-Response Relationship, Drug, Double-Blind Method, Electrocardiography, Female, Follow-Up Studies, Glycated Hemoglobin, Humans, Hypoglycemic Agents, Male, Middle Aged, Prospective Studies, Risk Factors, United States, Incidence, Prevalence, Survival Rate, Glycemic Index
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
